REFERENCES
- Aigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry, 12(6), 400–443. doi:10.3109/15622975.2011.602720
- Dore, G.M., Lo, K., Juckes, L., Bezyan, S., & Latt, N. (2011). Clinical experience with baclofen in the management of alcohol-dependent patients with psychiatric comorbidity: A selected case series. Alcohol and Alcoholism, 46(6), 714–720. doi:10.1093/alcalc/agr131
- Hadad, N.A., & Knackstedt, L.A. (2014). Addicted to palatable foods: Comparing the neurobiology of bulimia nervosa to that of drug addiction. Psychopharmacology, 231(9), 1897–1912. doi:/10.1007/s00213-014-3461-1
- Rigal, L., Alexandre-Dubroeucq, C., de Beaurepaire, R., Le Jeunne, C., & Jaury, P. (2012). Abstinence and “low-risk” consumption 1 year after the initiation of high-dose baclofen: A retrospective study among “high-risk” drinkers. Alcohol and Alcoholism, 47(4), 439–442. doi:10.1093/alcalc/ags028